CLINICAL_TRIALS
trial_result
· 2024-06-12
Clinical Trial Update: Prospective Study of Rapamycin for the Treatment of SLE [Phase 2]
Summary
A Phase 2 prospective trial evaluating rapamycin for systemic lupus erythematosus has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: State University of New York - Upstate Medical University | Conditions: Systemic Lupus Erythematosus (SLE) | Phase 2 | Status: COMPLETED | Results posted: 2024-06-12